Status:
COMPLETED
Asthma In-Home Monitoring (AIM) Trial
Lead Sponsor:
Tripler Army Medical Center
Collaborating Sponsors:
U.S. Army Medical Research Acquisition Activity
Conditions:
Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
OBJECTIVE: Determine whether home asthma telemonitoring using store-and-forward technology improves outcomes when compared to in-person, office-based visits.
Detailed Description
OBJECTIVE: Determine whether home asthma telemonitoring using store-and-forward technology improves outcomes when compared to in-person, office-based visits. METHODS: 120 patients 6-17 yrs with persi...
Eligibility Criteria
Inclusion
- Diagnosis of persistent asthma as defined using the NHLBI Expert Panel Report -2 guidelines Assignment of severity classification will be made at the beginning of the study based on severity of disease off therapy.
- Dependent of active duty or retired US military personnel
- 6 to 17 years of age
- Not moving from Oahu for 12 months after entry into study
- Ability to receive cable modem hook-up in home
- Willingness to learn to record and send MDI + spacer technique and peak flow two times week
- Willing to attend asthma education follow-up visits either in person or electronically at 2- weeks, 6- weeks, 3-months and 6-month intervals after initiation into the study.
- Willing to complete survey at the end of study period.
- Willing to sign informed, written consent
Exclusion
- Diagnosis of mild intermittent asthma as defined by Expert Panel Report -2 guidelines.
- \<6 and \>17 years of age
- Family leaving Oahu within 12 months
- Inability to receive cable modem hook-up in home
- Unwilling or unable to learn to record and send MDI + spacer technique and peak flow and/or to attend asthma education follow-up visits either in person or electronically at initiation into study and at 2- weeks, 6- weeks, 3-months and 6 month intervals.
- Unwilling to complete survey at the end of study period.
- Patients or parents who decline to participate.
- Patients with other chronic pulmonary disease (cystic fibrosis, bronchopulmonary dysplasia)
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2004
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00282516
Start Date
April 1 2003
End Date
April 1 2004
Last Update
February 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tripler Army Medical Center
Tripler AMC, Hawaii, United States, 96859-5000